{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:27:38Z","timestamp":1775795258373,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81973103"],"award-info":[{"award-number":["81973103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Project of Jiangsu Health Commission","award":["ZDB2020013"],"award-info":[{"award-number":["ZDB2020013"]}]},{"name":"Nanjing Major Science and Technology Specific Project","award":["2021-11005"],"award-info":[{"award-number":["2021-11005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-21954-7","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:08:44Z","timestamp":1740499724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative evaluation of QuantiFERON-TB gold in-tube plus for Mycobacterium tuberculosis infection among adolescents in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Peng","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"21954_CR1","unstructured":"Organization WH. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. World Health Organization; 2020."},{"issue":"9979","key":"21954_CR2","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H. WHO\u2019s new end TB strategy. Lancet. 2015;385(9979):1799\u2013801.","journal-title":"Lancet"},{"issue":"8","key":"21954_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/CVI.00199-15","volume":"22","author":"RT Horvat","year":"2015","unstructured":"Horvat RT. Gamma interferon assays used in the diagnosis of tuberculosis. Clin Vaccine Immunol. 2015;22(8):845\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"21954_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","volume":"73","author":"E Petruccioli","year":"2016","unstructured":"Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L, Cirillo DM, Palmieri F, Ippolito G. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus. J Infect. 2016;73(6):588\u201397.","journal-title":"J Infect"},{"issue":"1","key":"21954_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/thoraxjnl-2015-207811","volume":"71","author":"SH Wong","year":"2016","unstructured":"Wong SH, Gao Q, Tsoi KK, Wu WK, Tam L-s, Lee N, Chan FK, Wu JC, Sung JJ, Ng SC. Effect of immunosuppressive therapy on interferon \u03b3 release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis. Thorax. 2016;71(1):64\u201372.","journal-title":"Thorax"},{"issue":"3","key":"21954_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","volume":"75","author":"M Nikolova","year":"2013","unstructured":"Nikolova M, Markova R, Drenska R, Muhtarova M, Todorova Y, Dimitrov V, Taskov H, Saltini C, Amicosante M. Antigen-specific CD4-and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn Microbiol Infect Dis. 2013;75(3):277\u201381.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"21954_CR7","doi-asserted-by":"publisher","first-page":"e01870","DOI":"10.1128\/spectrum.01870-21","volume":"10","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yang Q, Zhou J, Zhou F, Hezhang Y, Gao Y, Shao L, Shi J, Ruan Q, Zhang W. Comparison of QuantiFERON-TB gold In-Tube and QuantiFERON-TB gold-plus in the diagnosis of mycobacterium tuberculosis infections in immunocompromised patients: a real-world study. Microbiol Spectr. 2022;10(2):e01870\u201301821.","journal-title":"Microbiol Spectr"},{"key":"21954_CR8","doi-asserted-by":"publisher","unstructured":"Ryu MR, Park M-S, Cho EH, Jung CW, Kim K, Kim SJ, Oh HY, Huh W, Jang HR, Koh W-J. Comparative evaluation of QuantiFERON-TB gold In-Tube and QuantiFERON-TB gold plus in diagnosis of latent tuberculosis infection in immunocompromised patients. J Clin Microbiol. 2018;56(11). https:\/\/doi.org\/10.1128\/jcm. 00438\u2013\u200900418.","DOI":"10.1128\/jcm"},{"issue":"3","key":"21954_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","volume":"24","author":"J Takasaki","year":"2018","unstructured":"Takasaki J, Manabe T, Morino E, Muto Y, Hashimoto M, Iikura M, Izumi S, Sugiyama H, Kudo K. Sensitivity and specificity of QuantiFERON-TB gold plus compared with QuantiFERON-TB gold In-Tube and T-SPOT. TB on active tuberculosis in Japan. J Infect Chemother. 2018;24(3):188\u201392.","journal-title":"J Infect Chemother"},{"key":"21954_CR10","unstructured":"Organization WH. Rapid communication: TB antigen-based skin tests for the diagnosis of TB infection. In.: World Health Organization; 2022."},{"issue":"4","key":"21954_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/cid\/ciab472","volume":"74","author":"M Xu","year":"2022","unstructured":"Xu M, Lu W, Li T, Li J, Du W, Wu Q, Liu Q, Yuan B, Lu J, Ding X. Sensitivity, specificity, and Safety of a Novel ESAT6-CFP10 skin test for tuberculosis infection in China: 2 Randomized, Self-Controlled, parallel-group phase 2b trials. Clin Infect Dis. 2022;74(4):668\u201377.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"21954_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1473-3099(21)00261-9","volume":"22","author":"M Krutikov","year":"2022","unstructured":"Krutikov M, Faust L, Nikolayevskyy V, Hamada Y, Gupta RK, Cirillo D, Mateelli A, Korobitsyn A, Denkinger CM, Rangaka MX. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-\u03b3 release assays: a systematic review and meta-analysis. Lancet Infect Dis. 2022;22(2):250\u201364.","journal-title":"Lancet Infect Dis"},{"key":"21954_CR13","unstructured":"Organization WH. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. World Health Organization; 2018."},{"issue":"4","key":"21954_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/cid\/ciab472","volume":"74","author":"M Xu","year":"2022","unstructured":"Xu M, Lu W, Li T, Li J, Du W, Wu Q, Liu Q, Yuan B, Lu J, Ding X, et al. Sensitivity, specificity, and Safety of a Novel ESAT6-CFP10 skin test for tuberculosis infection in China: 2 Randomized, Self-Controlled, parallel-group phase 2b trials. Clin Infect Dis. 2022;74(4):668\u201377.","journal-title":"Clin Infect Dis"},{"key":"21954_CR15","doi-asserted-by":"publisher","unstructured":"Theel ES, Hilgart H, Breen-Lyles M, McCoy K, Flury R, Breeher LE, Wilson J, Sia IG, Whitaker JA, Clain J. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers. J Clin Microbiol. 2018;56(7):00614\u20138. https:\/\/doi.org\/10.1128\/jcm","DOI":"10.1128\/jcm"},{"issue":"12","key":"21954_CR16","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.21037\/jtd.2019.12.11","volume":"11","author":"JY Hong","year":"2019","unstructured":"Hong JY, Park SY, Kim A, Cho S-N, Hur Y-G. Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. Tuberculosis infection in immunocompetent Korean subjects. J Thorac Disease. 2019;11(12):5210.","journal-title":"J Thorac Disease"},{"key":"21954_CR17","doi-asserted-by":"publisher","unstructured":"Won D, Park JY, Kim H-S, Park Y. Comparative results of QuantiFERON-TB gold In-Tube and QuantiFERON-TB Gold Plus assays for detection of tuberculosis infection in clinical samples. J Clin Microbiol. 2020;58(4). https:\/\/doi.org\/10.1128\/jcm. 01854\u2013\u200901819.","DOI":"10.1128\/jcm"},{"issue":"3","key":"21954_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4269\/ajtmh.18-0674","volume":"100","author":"AW Kay","year":"2019","unstructured":"Kay AW, DiNardo AR, Dlamini Q, Kahari J, Mndzebele T, Mtetwa G, Ustero P, Maphalala G, Mandalakas AM. Evaluation of the QuantiFERON-Tuberculosis gold plus assay in children with tuberculosis disease or following household exposure to tuberculosis. Am J Trop Med Hyg. 2019;100(3):540.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"21954_CR19","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1093\/cid\/ciaa1822","volume":"73","author":"CE Oh","year":"2021","unstructured":"Oh CE, Ortiz-Brizuela E, Bastos ML, Menzies D. Comparing the diagnostic performance of QuantiFERON-TB Gold Plus to other tests of latent tuberculosis infection: a systematic review and meta-analysis. Clin Infect Dis. 2021;73(5):e1116\u201325.","journal-title":"Clin Infect Dis"},{"key":"21954_CR20","doi-asserted-by":"publisher","unstructured":"Shafeque A, Bigio J, Hogan CA, Pai M, Banaei N. Fourth-generation QuantiFERON-TB gold plus: what is the evidence? J Clin Microbiol. 2020;58(9). https:\/\/doi.org\/10.1128\/jcm. 01950\u2013\u200901919.","DOI":"10.1128\/jcm"},{"key":"21954_CR21","doi-asserted-by":"publisher","unstructured":"Chien J-Y, Chiang H-T, Lu M-C, Ko W-C, Yu C-J, Chen Y-H, Hsueh P-R. QuantiFERON-TB Gold Plus is a more sensitive screening tool than QuantiFERON-TB gold In-Tube for latent tuberculosis infection among older adults in long-term care facilities. J Clin Microbiol. 2018;56(8). https:\/\/doi.org\/10.1128\/jcm. 00427\u2013\u200900418.","DOI":"10.1128\/jcm"},{"issue":"2","key":"21954_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3904\/kjim.2019.002","volume":"35","author":"SH Kim","year":"2020","unstructured":"Kim SH, Jo K-W, Shim TS. QuantiFERON-TB gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection. Korean J Intern Med. 2020;35(2):383.","journal-title":"Korean J Intern Med"},{"issue":"3","key":"21954_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5588\/pha.23.0020","volume":"13","author":"AL Innes","year":"2023","unstructured":"Innes AL, Nguyen ST, Lebrun V, Nguyen TTH, Huynh TP, Quach VL, Hoang GL, Nguyen TB, Nguyen TBP, Pham HM, et al. Tuberculin skin testing and QuantiFERON\u2122-TB gold plus positivity among household contacts in Vietnam. Public Health Action. 2023;13(3):83\u20139.","journal-title":"Public Health Action"},{"key":"21954_CR24","doi-asserted-by":"crossref","unstructured":"Venkatappa TK, Punnoose R, Katz DJ, Higgins MP, Banaei N, Graviss EA, Belknap RW, Ho CS. Comparing QuantiFERON-TB gold plus with other tests to diagnose Mycobacterium tuberculosis infection. J Clin Microbiol 2019;57(11).","DOI":"10.1128\/JCM.00985-19"},{"key":"21954_CR25","doi-asserted-by":"crossref","unstructured":"Primaturia C, Reniarti L, Nataprawira HMN. Comparison between the Interferon \u03b3 Release Assay-QuantiFERON Gold Plus (QFT-Plus)-and Tuberculin Skin Test (TST) in the Detection of Tuberculosis Infection in Immunocompromised Children. Pulm Med, 2020:7159485.","DOI":"10.1155\/2020\/7159485"},{"issue":"6","key":"21954_CR26","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/eji.201243262","volume":"43","author":"V Rozot","year":"2013","unstructured":"Rozot V, Vigano S, Mazza-Stalder J, Idrizi E, Day CL, Perreau M, Lazor\u2010Blanchet C, Petruccioli E, Hanekom W, Goletti D. Mycobacterium tuberculosis\u2010specific CD8\u2009+\u2009T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol. 2013;43(6):1568\u201377.","journal-title":"Eur J Immunol"},{"issue":"2","key":"21954_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","volume":"187","author":"JZ Metcalfe","year":"2013","unstructured":"Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med. 2013;187(2):206\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"21954_CR28","doi-asserted-by":"crossref","unstructured":"Whitworth WC, Hamilton LR, Goodwin DJ, Barrera C, West KB, Racster L, Daniels LJ, Chuke SO, Campbell BH, Bohanon J. Within-subject interlaboratory variability of QuantiFERON-TB gold In-Tube tests. 2012.","DOI":"10.1371\/journal.pone.0043790"},{"issue":"4","key":"21954_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/JCM.02803-15","volume":"54","author":"N Banaei","year":"2016","unstructured":"Banaei N, Gaur RL, Pai M. Interferon gamma release assays for latent tuberculosis: what are the sources of variability? J Clin Microbiol. 2016;54(4):845\u201350.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"21954_CR30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","volume":"196","author":"E Nemes","year":"2017","unstructured":"Nemes E, Rozot V, Geldenhuys H, Bilek N, Mabwe S, Abrahams D, Makhethe L, Erasmus M, Keyser A, Toefy A, et al. Optimization and interpretation of serial QuantiFERON testing to measure Acquisition of Mycobacterium tuberculosis infection. Am J Respir Crit Care Med. 2017;196(5):638\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"21954_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/cid\/ciw778","volume":"64","author":"DM Lewinsohn","year":"2017","unstructured":"Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, et al. Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):111\u20135.","journal-title":"Clin Infect Dis"},{"key":"21954_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","volume":"108","author":"ED Pieterman","year":"2018","unstructured":"Pieterman ED, Liqui Lung FG, Verbon A, Bax HI, Ang CW, Berkhout J, Blaauw G, Brandenburg A, van Burgel ND, Claessen A, et al. A multicentre verification study of the QuantiFERON(\u00ae)-TB gold plus assay. Tuberculosis (Edinb). 2018;108:136\u201342.","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"21954_CR33","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1128\/JCM.02498-16","volume":"55","author":"H-W Moon","year":"2017","unstructured":"Moon H-W, Gaur RL, Tien SS-H, Spangler M, Pai M, Banaei N. Evaluation of QuantiFERON-TB gold-plus in health care workers in a low-incidence setting. J Clin Microbiol. 2017;55(6):1650\u20137.","journal-title":"J Clin Microbiol"},{"key":"21954_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","volume":"106","author":"E Petruccioli","year":"2017","unstructured":"Petruccioli E, Vanini V, Chiacchio T, Cuzzi G, Cirillo DM, Palmieri F, Ippolito G, Goletti D. Analytical evaluation of QuantiFERON-Plus and QuantiFERON-Gold In-tube assays in subjects with or without tuberculosis. Tuberculosis. 2017;106:38\u201343.","journal-title":"Tuberculosis"},{"issue":"1","key":"21954_CR35","doi-asserted-by":"publisher","first-page":"30617","DOI":"10.1038\/srep30617","volume":"6","author":"L Yi","year":"2016","unstructured":"Yi L, Sasaki Y, Nagai H, Ishikawa S, Takamori M, Sakashita K, Saito T, Fukushima K, Igarashi Y, Aono A. Evaluation of QuantiFERON-TB Gold Plus for detection of Mycobacterium tuberculosis infection in Japan. Sci Rep. 2016;6(1):30617.","journal-title":"Sci Rep"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21954-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-21954-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21954-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:08:53Z","timestamp":1740499733000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-21954-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21954"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-21954-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study underwent a comprehensive review and obtained ethical approval from the Jiangsu Provincial Center for Disease Control and Prevention ethics committee. Informed consent in written form was obtained from all eligible subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"778"}}